首页|期刊导航|中华医学杂志(英文版)|Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019:a systematic review and network meta-analysis combining 66 trials
Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019:a systematic review and network meta-analysis combining 66 trials
Shan-Shan Wu Si-Yan Zhan Qing-Xin Zhou Xue-Yang Zeng Jing-Xue Zhang Zhi-Rong Yang Qing-Qing Yang Zi-Lu Zhang Ya-Hong Chen Feng Sun
中华医学杂志(英文版)2021,Vol.134Issue(16):1920-1929,10.
中华医学杂志(英文版)2021,Vol.134Issue(16):1920-1929,10.DOI:10.1097/CM9.0000000000001672
Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019:a systematic review and network meta-analysis combining 66 trials
Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019:a systematic review and network meta-analysis combining 66 trials
摘要
关键词
SARS-CoV-2/COVID-19/Pharmacological intervention/Network meta-analysis/Effectiveness/SafetyKey words
SARS-CoV-2/COVID-19/Pharmacological intervention/Network meta-analysis/Effectiveness/Safety引用本文复制引用
Shan-Shan Wu,Si-Yan Zhan,Qing-Xin Zhou,Xue-Yang Zeng,Jing-Xue Zhang,Zhi-Rong Yang,Qing-Qing Yang,Zi-Lu Zhang,Ya-Hong Chen,Feng Sun..Comparative effectiveness and safety of 32 pharmacological interventions recommended by guidelines for coronavirus disease 2019:a systematic review and network meta-analysis combining 66 trials[J].中华医学杂志(英文版),2021,134(16):1920-1929,10.基金项目
This study is funded by grants from the National Natural Science Foundation of China(No.72074011),the Special Project for Major Infectious Disease of Peking University Health Program of China(No.BMU2020HKYZX010),and the National Key Technology R&D Program of China(No.2020YFC0840800). (No.72074011)